Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-17-03 | Thyroid Cancer Diagnosis 2 | ETA2023

Role of cervical ultrasound in the pre-operative evaluation of central compartment lymph nodes in thyroid cancer

Retta Francesca , Mormile Albeto , Josefina Ramunni Maria , Sapino Silvia , Caracciolo Alessandra , Ravera Alberto , Canale Giovanni , Deandrea Maurilio

Background and Objective: In thyroid cancer (TC) central compartment (CC) neck dissection (CCND) should accompany thyroidectomy in case of clinical and/or cytological suspicion of lymph node (LN) metastases. Cervical ultrasound has been indicated as the first-line examination in the pre-operative staging of TC, although its diagnostic performance in evaluating CC LN is controversial. Proving that cervical ultrasound can accurately identify CC metastases would allow to use this...

ea0081rc3.7 | Rapid Communications 3: Thyroid 1 | ECE2022

Immune-related thyroid dysfunctions during PD-1/PD-L1 inhibitors and their association to the oncological outcome: new evidence

Ferrari Matteo , Anna Nervo Alice , Basile Sara , Migliore Enrica , D'Angelo Valentina , Gruosso Giovanni , Rosso Daniela , Retta Francesca , Piovesan Alessandro , Arvat Emanuela

Background: Immune checkpoint inhibitors (ICIs) showed impressive results in several malignancies; however, a large spectrum of immune-related adverse events (IRAEs) may occur, including thyroid dysfunction (DYSTHYR). IRAEs seem to be associated with better cancer outcome; limited data suggested that thyroid toxicity could be a predictor of response to ICIs.Patients and methods: We retrospectively evaluated all patients who started treatment with the pro...

ea0099p576 | Thyroid | ECE2024

Radiofrequency ablation is an effective treatment for bethesda iii nodules without genetic alterations

Fugazzola Laura , Deandrea Maurilio , Borgato Stefano , Dell'Acqua Marco , Retta Francesca , Mormile Alberto , Carzaniga Chiara , Gazzano Giacomo , Pogliaghi Gabriele , Muzza Marina , Persani Luca

Radiofrequency ablation (RFA) is effective in the treatment of thyroid nodules, leading to a 50-90% reduction with respect to baseline. Current guidelines indicate the need for a benign cytology prior to RFA, though, on the other side, this procedure is also successfully used for the treatment of papillary microcarcinomas. No specific indications are available for nodules with an indeterminate cytology (Bethesda III and IV). Aim of the present study was to evaluate the efficac...